Replies to post #7114 on Asberry 22 Holdings Inc (ASHI)

[bernardsamuel]

Thanks, Knife, as ever. I think your point about the congruence of interests of the major stockholding group with that of the remaining shareholders can't be emphasized enough.

Meanwhile, one overlooked aspect at this time of our all concentrating on the upcoming transaction is how deeply the stock appears to be undervalued currently without consideration of an upcoming transaction, based particularly on sales growth and the first quarter bottom line, even before one might consider how much more a transaction would bring to the share price. it would appear to me, the way things seem to be going, that the company would actually be likely to be able to pay for a large measure of the costs of FDA compliance, even if assuming no pullback on the regulations, through earnings-generated funds.

Best wishes!

[cashbyers]

These are my exact thoughts as well.

My focus remains on how undervalued I believe the stock is and my own expectation that it will trade significantly higher in the next few weeks. However the asset purchase agreement ends up being structured is almost irrelevant to me as long as it is actually completed.

I trust the management here (rare for me on the OTC) and with the Winthers large shareholdings it brings their interests in line with that of other shareholders like myself.